Cargando…

ER-α36-mediated gastric cancer cell proliferation via the c-Src pathway

Previously, a novel variant of estrogen receptor (ER)-α, ER-α36, was identified and cloned and reported to mainly mediate non-genomic estrogen signaling. More recently, we identified that ER-α36 is important for the invasion and lymph node metastasis of human gastric cancer. In the present study, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	WANG, XUMING, DENG, HAO, ZOU, FENG, FU, ZHENQI, CHEN, YING, WANG, ZHAOYI, LIU, LIJIANG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789085/ https://www.ncbi.nlm.nih.gov/pubmed/24137325 http://dx.doi.org/10.3892/ol.2013.1416

Ejemplares similares

Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression
por: Wang, Xuming, et al.
Publicado: (2017)

Involvement of the Akt signaling pathway in ER-α36/GRP94-mediated signaling in gastric cancer
por: FU, ZHENGQI, et al.
Publicado: (2014)

ER-α36, a Novel Variant of ER-α, Mediates Estrogen-Stimulated Proliferation of Endometrial Carcinoma Cells via the PKCδ/ERK Pathway
por: Tong, Jing-Shan, et al.
Publicado: (2010)

Huaier polysaccharide inhibits the stem-like characteristics of ERα-36(high) triple negative breast cancer cells via inactivation of the ERα-36 signaling pathway
por: Hu, Baoquan, et al.
Publicado: (2019)

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36
por: Acramel, Alexandre, et al.
Publicado: (2022)

ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
por: Deng, Hao, et al.
Publicado: (2014)

ER-α36, a Variant of ER-α, Promotes Tamoxifen Agonist Action in Endometrial Cancer Cells via the MAPK/ERK and PI3K/Akt Pathways
por: Lin, Sheng-Li, et al.
Publicado: (2010)

Estrogen Receptor-α36 Is Involved in Pterostilbene-Induced Apoptosis and Anti-Proliferation in In Vitro and In Vivo Breast Cancer
por: Pan, Chi, et al.
Publicado: (2014)

Fas expression is downregulated in gastric cancer
por: Wang, Xuming, et al.
Publicado: (2017)

Chaperone gp96 mediates ER-α36 cell membrane expression
por: Hou, Junwei, et al.
Publicado: (2015)

The Role of ERα36 in Development and Tumor Malignancy
por: Thiebaut, Charlène, et al.
Publicado: (2020)

ER-α36 mediates cisplatin resistance in breast cancer cells through EGFR/HER-2/ERK signaling pathway
por: Zhu, Linlin, et al.
Publicado: (2018)

ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
por: Wang, Chunyan, et al.
Publicado: (2021)

Cyanidin-3-o-glucoside directly binds to ERα36 and inhibits EGFR-positive triple-negative breast cancer
por: Wang, Li, et al.
Publicado: (2016)

Down‐regulation of ER‐α36 mRNA in serum exosomes of the patients with hepatocellular carcinoma
por: Huang, Hui, et al.
Publicado: (2020)

Estrogen receptor variant ER‐α36 promotes tamoxifen agonist activity in glioblastoma cells
por: Qu, Chao, et al.
Publicado: (2019)

ERα-36 regulates progesterone receptor activity in breast cancer
por: Konan, Henri-Philippe, et al.
Publicado: (2020)

Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer
por: Liu, Yanfang, et al.
Publicado: (2019)

Interaction of Coumarin Phytoestrogens with ER(α) and ER(β): A Molecular Dynamics Simulation Study
por: Wang, Ting, et al.
Publicado: (2020)

Tamoxifen enhances stemness and promotes metastasis of ERα36(+) breast cancer by upregulating ALDH1A1 in cancer cells
por: Wang, Qiang, et al.
Publicado: (2018)

Systematic Proteomic Identification of the Heat Shock Proteins (Hsp) that Interact with Estrogen Receptor Alpha (ERα) and Biochemical Characterization of the ERα-Hsp70 Interaction
por: Dhamad, Ahmed E., et al.
Publicado: (2016)

The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells
por: Park, Miso, et al.
Publicado: (2022)

A Positive Feedback Loop of ER-α36/EGFR Promotes Malignant Growth of ER-negative Breast Cancer Cells
por: Zhang, XianTian, et al.
Publicado: (2010)

The molecular mechanisms underlying the ERα-36-mediated signaling in breast cancer
por: Omarjee, S, et al.
Publicado: (2017)

Dual Epigenetic Regulation of ERα36 Expression in Breast Cancer Cells
por: Thiebaut, Charlène, et al.
Publicado: (2019)

From ERα66 to ERα36: a generic method for validating a prognosis marker of breast tumor progression
por: Chamard-Jovenin, Clémence, et al.
Publicado: (2015)

RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
por: Zhang, Xiaomeng, et al.
Publicado: (2017)

Enhancement of Sensitivity to Tamoxifen by Berberine in Breast Cancer Cells by Inhibiting ER-α36 Expression
por: Pan, Xiaohua, et al.
Publicado: (2022)

FBXW5 Promotes Tumorigenesis and Metastasis in Gastric Cancer via Activation of the FAK-Src Signaling Pathway
por: Yeo, Mei Shi, et al.
Publicado: (2019)

Salidroside inhibits the proliferation and migration of gastric cancer cells via suppression of Src-associated signaling pathway activation and heat shock protein 70 expression
por: Qi, Zhilin, et al.
Publicado: (2018)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment
por: Liu, Li-Zhong, et al.
Publicado: (2023)

Oestrogen receptor-α contributes to the regulation of the hedgehog signalling pathway in ERα-positive gastric cancer
por: Kameda, C, et al.
Publicado: (2010)

Estrogen Receptor (ER)-α36 Is Involved in Estrogen- and Tamoxifen-Induced Neuroprotective Effects in Ischemic Stroke Models
por: Zou, Wei, et al.
Publicado: (2015)

Lidocaine suppresses the malignant behavior of gastric cancer cells via the c-Met/c-Src pathway
por: Zeng, Wei, et al.
Publicado: (2021)

Novel interactions between ERα-36 and STAT3 mediate breast cancer cell migration
por: Xiang, Yuan, et al.
Publicado: (2019)

Influence of Cellular ERα/ERβ Ratio on the ERα-Agonist Induced Proliferation of Human T47D Breast Cancer Cells
por: Covaleda, Ana M. Sotoca, et al.
Publicado: (2008)

SRC kinase-mediated signaling pathways and targeted therapies in breast cancer
por: Luo, Juan, et al.
Publicado: (2022)

TTC36 inactivation induce malignant properties via Wnt-β-catenin pathway in gastric carcinoma
por: Song, Lei, et al.
Publicado: (2021)

High ERα36 Expression Level and Membrane Location Predict Poor Prognosis in Renal Cell Carcinoma
por: Wang, Qiang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a50f5v5de5c6vruafg7ae1krie